Dual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Dual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis

Published:2016-03-28 Issue:6 Volume:23 Page:1051-1057
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Ge F.¹,Lin H.¹,Liu Y.¹,Li M.¹,Guo R.¹,Ruan Z.¹,Chang T.¹

Affiliation:

1. Department of Neurology; Tangdu Hospital; Fourth Military Medical University; Shaanxi Province China

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12982/fullpdf

Reference31 articles.

1. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee;Lloyd-Jones;Circulation,2009

2. Short-term prognosis after emergency department diagnosis of TIA;Johnston;JAMA,2000

3. Very early risk of stroke after a first transient ischemic attack;Lovett;Stroke,2003

4. The high risk of stroke immediately after transient ischemic attack: a population-based study;Hill;Neurology,2004

5. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease;Gum;J Am Coll Cardiol,2003

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 Hours After Mild Ischemic Stroke and Transient Ischemic Attack;Neurology;2024-10-08

2. RGB-algorithm whiteness appraisal approach for quantitative determination of clopidogrel and aspirin in presence of salicylic acid as a degradation product based on proton NMR technique;Microchemical Journal;2024-08

3. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles;JAMA Neurology;2022-08-01

4. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial;JAMA NEUROL;2022

5. Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack;Neurology;2022-04-18